Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 09:05:31 31/05/2024 pm IST			5-day change	1st Jan Change
39.18 ^EUR	+0.31%		+0.46%	+3.21%

28/05	FMC briefly burdened by research success in the fight against diabetes	DP
28/05	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg reaffirms its Buy rating	ZD

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from JP Morgan

May 20, 2024 at 11:21 am IST

In a research note published by David Adlington, JP Morgan advises its customers to Sell the stock. The target price is reviewed upwards from EUR 35.40 to EUR 42.30.

Latest news about Fresenius Medical Care AG

FMC briefly burdened by research success in the fight against diabetes	28/05	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg reaffirms its Buy rating	28/05	ZD
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	24/05	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan remains a Sell rating	24/05	ZD
FMC, Fresenius and Davita rise after Ozempic news	24/05	DP
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	22/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	21/05	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from JP Morgan	20/05	ZD
Life Healthcare Group Holdings Limited agreed to acquire Assets and Operations of 51 Renal Dialysis Clinics of Fresenius Medical Care AG.	19/05	CI
Moody’s Revises Outlook on Fresenius Medical Care to Stable from Negative	17/05	MT
Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability	16/05	MT
Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating	15/05	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Sell rating from Jefferies	14/05	ZD
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...	13/05
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Buy rating from Berenberg	13/05	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating	13/05	ZD
FRESENIUS MEDCARE : adjusted target price at Barclays	13/05	CF
Fresenius Medical sees up to 2% US dialysis growth by year-end	11/05	RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	10/05	MT
Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup	09/05	DJ
Home REIT cuts borrowings, Genflow shares restored	09/05	AN
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	08/05	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank sticks Neutral	08/05	ZD
Fresenius becomes more optimistic thanks to subsidiary Kabi - exit from Vamed	08/05	DP
Dpa-AFX Overview: COMPANIES from 08.05.2024 - 15:15	08/05	DP

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

30/07/2024 - Q2 2024 Earnings Call

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Are the 2025 targets achievable?

May 08, 2024 at 02:16 am IST

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

39.18 EUR

Average target price

39.92 EUR

Spread / Average Target

+1.89%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	+3.21%	12.47B
HCA HEALTHCARE, INC.	+25.52%	88.99B
CVS HEALTH CORPORATION	-24.52%	74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.49%	25.03B
FRESENIUS SE & CO. KGAA	+4.31%	17.88B
LABCORP HOLDINGS INC.	-14.25%	16.43B
QUEST DIAGNOSTICS INCORPORATED	+2.97%	15.77B
TENET HEALTHCARE CORPORATION	+79.20%	13.21B
NATERA, INC.	+70.11%	13.08B
DAVITA INC.	+40.44%	12.9B

Other Healthcare Facilities & Services

Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from JP Morgan

EPS Revisions